[图书][B] Reinforcement Learning and Stochastic Optimization: A Unified Framework for Sequential Decisions: by Warren B. Powell (ed.), Wiley (2022). Hardback. ISBN …

I Halperin - 2022 - Taylor & Francis
What is reinforcement learning? How is reinforcement learning different from stochastic
optimization? And finally, can it be used for applications to quantitative finance for my current …

Developing operations management data analytics

Q Feng, JG Shanthikumar - Production and Operations …, 2022 - journals.sagepub.com
In this article, we describe representative contributions in several major application areas of
data analytics in operations management to summarize the recent development, discuss the …

Health decision analysis: Evolution, trends, and emerging topics

EF Long, G Montibeller, J Zhuang - Decision Analysis, 2022 - pubsonline.informs.org
Health remains one of the most challenging realms for decision makers and policy making
while critical for the well-being of humans, the stability of societies, and the development of …

Clinical site selection problems with probabilistic constraints

A Ninh, Y Bao, D McGibney, T Nguyen - European Journal of Operational …, 2024 - Elsevier
Recruiting candidates globally and across multiple sites in different geographic regions is
necessary to speed up the enrollment of clinical trials. While patient enrollment can benefit …

EXPRESS: Learning to Balance the Performance and Deterioration of Aging Systems through Derating

J Wang - Production and Operations Management, 2024 - journals.sagepub.com
A common strategy of extending the lifetime of an aging system is to reduce its workload
below the normal operating level, a practice known as derating. While derating can slow the …

Optimizing Patient Recruitment for Clinical Trials: A Hybrid Classification Model and Game-Theoretic Approach for Strategic Interaction

OK ChandraUmakantham, I Singh, S Marappan - IEEE Access, 2024 - ieeexplore.ieee.org
This research is imperative due to the pressing need for improved patient recruitment in
clinical trials, addressing challenges such as delays and high costs. By introducing a …

Optimal Enrollment in Late-Stage New Drug Development with Learning of Drug's Efficacy for Group-Sequential Clinical Trials

Z Tian, GB Hazen, H Li - Manufacturing & Service …, 2023 - pubsonline.informs.org
Problem definition: The cost for developing a new drug ranged from 1billiontomorethan 2
billion between 2010 and 2019. In addition to high development costs, the efficacy of the …

Collaboration in development of new drugs

Z Tian, H Gurnani, Y Xu - Production and Operations …, 2021 - journals.sagepub.com
The development of a new drug is costly and uncertain. As such, pharmaceutical firms often
collaborate to develop new drugs. We examine the conditions under which firms should …

An analysis of incentive schemes for participant retention in clinical studies

X Song, M Mehrotra… - Manufacturing & Service …, 2023 - pubsonline.informs.org
Problem definition: Participant retention is one of the significant issues faced by clinical
studies. This paper analyzes the economic impact of combining two mechanisms (monetary …

Timing of Collaboration in Development of New Drugs with Learning of Efficacy

Z Tian, H Gurnani, Y Xu - Available at SSRN 4884956, 2024 - papers.ssrn.com
Abstract Problem Definition-Drug development is expensive and time-consuming requiring
multiple phases of testing. Because of the uncertainties in development, the process is also …